Glenmark also denied making any claims that favipiravir alone is effective in treatment of mild-to-moderate COVID-19...
21 July 2020 3:38 PM IST
Shares of Mumbai-based Glenmark Pharmaceuticals, which rose as much as 8.9% to 359 rupees ($4.78), was trading up 5.9%
30 April 2020 12:28 PM IST
